… Antiplatelet Therapy Guideline Update This update to the 2011 and 2013 Canadian
Cardiovascular Society (CCS) antiplatelet therapy … to optimally use antiplatelet therapy, particularly …

… Canadian Cardiovascular Society (CCS) released the original practice guidelines on the use
of antiplatelet therapy (APT) in the outpatient setting in … ) on the use of antiplatelet agents in …

… Canadian cardiologists from six provinces (Appendix S1), including those who had
participated in previous practice assessments with the Canadian Heart Research Centre (CHRC), …

… use of antiplatelet therapy in acute coronary syndromes, as well as updates to the Canadian
and European Society of Cardiology … Cardiac Societies. 2017 ESC focused update on dual …

… A substantial body of literature regarding the efficacy and safety of antithrombotic therapy in
… the association between BP control and CV outcomes have used a 24-hour ambulatory BP …

… antiplatelet or anticoagulant therapy alone is clearly defined in the literature. The dilemma is
that the use of … On this basis, the Canadian Cardiovascular Society (CCS) 2018 antiplatelet …

… Canadian Cardiovascular Society antiplatelet therapy guidelines recommend the use of …
as first-line platelet P2Y12 receptor antagonists for treatment of moderate- to high-risk acute …

… it is not endorsed by a cardiovascular society. Since then, … type of OAC agent and the duration
of antiplatelet treatment have … the Canadian Cardiovascular Society Antiplatelet Guidelines …

… Antithrombotic prescriptions were defined as any antiplatelet or anticoagulant agent
prescribed by a community or hospital prescriber to a HD patient from the TGH HD outpatient unit. …

… divided into vascular protection (dual antiplatelet therapy, lipid-… heart failure symptoms,
reduce heart failure morbidity, and improve survival. Recent Canadian Cardiovascular Society …